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Summary
Angiogenic defects in Id mutant mice inhibit the growth of tumor xenografts, providing a genetic model for antiangiogenic
stress. Our work tests the consequences of such stress on progression of more physiological Pten/ tumors. While tumor
growth occurs despite impaired angiogenesis, disruption of vasculature by Id loss causes tumor cells to experience hypoxia
and necrosis, the extent of which is tumor dependent. We show that bone-marrow-derived endothelial precursors contribute
functionally to neovasculature of some but not all Pten/ tumors, partially rescuing Id mutant phenotype. We demonstrate
that loss of Id1 in tumor endothelial cells results in downregulation of several proangiogenic genes, including 6 and 4
integrins, matrix metalloprotease-2, and fibroblast growth factor receptor-1. Inhibition of these factors phenocopies loss
of Id in in vivo angiogenesis assays.
Introduction cally relevant to human malignancies (Carmeliet and Jain, 2000).
Xenograft models may exaggerate antiangiogenic and antitumor
responses (Carmeliet and Jain, 2000; Bergers et al., 1999). Thus,Id proteins regulate transcription by sequestering bHLH tran-
we were interested in the role of Id genes in the vascularization ofscription factors and forming heterodimers that are unable to
spontaneous tumors, which arise from cells in well-vascularizedbind DNA (Ruzinova and Benezra, 2003). Id1 and Id3 are re-
tissues and progress through multiple stages. Since the hostquired for proper angiogenesis during mouse brain develop-
organ can affect the biology of the tumor, our goal was toment. Complete loss of these genes leads to aggregation of
evaluate Id mutant vasculature in tumors of different origins.dilated and irregularly shaped blood vessels and brain hemor-
To address this question, we crossed Id1/ Id3/ mice withrhage by E13.5. Id proteins are also important in tumor angio-
Pten/ mice. The Pten gene encodes a phosphatase homozy-genesis. Adult Id1/ Id3/mice exhibit a block in neovasculari-
gously mutated in a high percentage of human tumors. A major
zation and consequently resist the growth of B6RV2 lymphoma substrate of PTEN is phosphatidylinositol triphosphate (PIP-3),
and B-CA breast cancer cells injected subcutaneously. Growth a lipid second messenger produced by PI 3-kinase. In the ab-
of Lewis lung carcinoma (LLC) xenograft line does occur, but sence of PTEN activity, PIP-3 levels are upregulated, leading
no metastases occur in the Id mutant background. In all cases, to enhanced phosphorylation and activation of the survival-
xenografts grown in Id1/Id3 / animals are hemorrhagic and promoting factor Akt/PKB. Pten/ mice exhibit hyperplastic-
necrotic with stunted and occluded vasculature (Lyden et al., dysplastic features such as lymph hyperplasia and high tumor
1999). incidence, including uterine carcinomas, prostate intraepithelial
Since xenografts grow subcutaneously, they do not develop neoplasias (PINs), and pheochromocytomas (Di Cristofano et
al., 1999, 2001).in a common site for human tumors and may not be physiologi-
S I G N I F I C A N C E
Our work demonstrates that the response of spontaneously arising tumors to severe angiogenic stress is very different from that
observed in tumor xenografts. In spontaneous tumors, the consequence of angiogenesis inhibition by Id loss varies in severity
depending on the tumor type, with some tumors growing to a large size despite hypoxic stress. Spontaneous tumors also show much
more variability in their dependence on bone-marrow-derived endothelial precursors than xenografts, which may explain the
observed differences in response to Id deficiency. We also identify multiple downstream targets of Id1 in endothelial cells of
spontaneous tumors, demonstrating that Id regulates several angiogenic pathways in vivo. Overall, our results point to new strategies
for the development and use of antiangiogenic drugs.
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Loss of Id in Pten/ tumors that normally express Id1 and of up to three copies of Id1 and Id3 did not reduce the rate of
Id3 in the vasculature, such as lymph hyperplasia and uterine occurrence (Supplemental Figure S1A at http://www.cancercell.
carcinoma, results in hemorrhage and necrosis, the extent of org/cgi/content/full/4/4/277/DC1), and loss of two copies of Id
which is tumor dependent. No histological changes were found did not delay the onset of lymphocytic growths (Figure 1A). Loss
in tumors that do not usually overexpress Id1 in their vascula- of three copies of Id conferred a slight but statistically significant
ture, confirming that the observed phenotypes were due to delay in the onset of lymphadenopathy (Figure 1A).
disruption of angiogenesis. While severe angiogenic stress in- A high percentage of female Pten/ mice also develop in
duced by loss of Id impaired survival of uterine tumor cells, situ uterine carcinomas (Di Cristofano et al., 2001). Histological
hyperplastic lymphoid lesions continue to grow to a large size examination of Pten/ Id-wild-type and Id mutant female mice
despite the vascular defect. Continued proliferation of hyper- revealed that occurrence of uterine malignancies was not re-
plastic lymph cells in the presence of impaired vasculature ques- duced in the absence of Id copies (Figure 1B).
tions the notion that tumors will not grow past 1–2 mm without Pten/ mice also develop other tumors such as PINs and
oxygen and nutrients delivered by functional vasculature (Car- pheochromocytomas (Di Cristofano et al., 2001). The incidence
meliet and Jain, 2000; Kerbel, 2000). of these malignancies was similar in Id-wild-type and Id-defi-
Vascularization of xenografts occurs primarily through re- cient backgrounds (Supplemental Figure S1A). The absence of
cruitment of bone-marrow (BM)-derived circulating endothelial an effect on the onset of tumors in the Id mutant animals is
precursors (CEPs). Impaired mobilization of endothelial precur- consistent with the finding that expression of Id is not detected
sors is responsible for the block in xenograft vascularization in these tumor cells but is confined to the tumor vasculature
and growth in Id-deficient mice (Lyden et al., 2001). We demon- (see below).
strate that Pten/ spontaneous tumors show much more vari-
ability in their dependence on BM-derived precursors, with Id-deficient lymph and uterine tumors exhibit necrosis
lymph hyperplasias showing no evidence of BM-derived vascu- and hemorrhage
lature and uterine carcinomas incorporating BM-derived CEPs The hyperplastic lymphoid tissue in Pten/ Id wild-type mice
into 15%–20% of their neovessels. Importantly, this 15%–20% has no detectable hemorrhage or necrosis (Figure 1C). In con-
contribution is functionally significant, since impaired tumor cell trast, microscopic hemorrhage and cellular necrosis were com-
survival and increased hemorrhage and necrosis observed in monly observed in Id mutant tissue samples (Figure 1D). The
the Id-deficient background are partially rescued by wild-type
extent of tissue damage appeared to be similar in tissues lacking
bone marrow transplantation. The difference in incorporation of
two or three copies of the Id genes in various combinations
BM-derived precursors may explain the difference in response
(Supplemental Figures S1B–S1D).of Pten/ spontaneous tumors to Id-deficiency, if loss of Id
On gross examination, Pten/ uterine carcinomas werepartially impairs the integrity of sprouting and co-opted vascula-
rarely hemorrhagic and never exhibited gross necrosis (Figureture while completely inhibiting mobilization of CEPs.
1E). In contrast, Pten/Id1/ and Pten/Id1/Id3/ uterineId proteins control lineage determination, differentiation, and
tumors almost always exhibited gross hemorrhage and fre-proliferation in a number of diverse cell types by regulating
quently had extensive necrosis (Figure 1E). Histological exami-transcriptional networks (Ruzinova and Benezra, 2003). Thus,
nation further confirmed that uterine tumors in Id mutant miceId proteins’ role in angiogenesis may be to regulate the expres-
were extensively hemorrhagic and necrotic in contrast to uterinesion of a variety of angiogenic molecules. We used microarray
carcinomas from Pten/ animals, which were mostly well-dif-technology to identify angiogenic factors misregulated in Id1/
ferentiated tumors, with only some localized central hemorrhagetumor endothelium. Several proangiogenic genes were down-
and necrosis (Figures 1F and 1G). Similar to lymph hyperplasia,regulated in the Id1/ endothelial cells, including 6 and 4
the combination of missing Id1 and/or Id3 copies did not affectintegrins, MMP-2, and FGFR-1, as well as members of ephrin
the resulting phenotype (Supplemental Figures S1E–S1G).and IGF2 families. However, we found no evidence that the
Quantitative assessment of tumor composition has demon-angiogenic defect observed in Id-deficient tumors is the result
strated a significant increase in hemorrhage and necrosis andof thrombospondin-1 (TSP-1) upregulation, recently reported in
a significant decrease in viable tumor tissue in Pten/ Id mutantId1/mouse embryonic fibroblasts (MEFs) (Volpert et al., 2002).
uterine malignancies as compared to Pten/ Id wild-type tu-In vivo matrigel assays confirmed importance of the identified
mors (Figure 1H). The nonneoplastic uterine wall appeared todownstream targets of Id1 in the development of a neovascula-
be histologically normal (Figures 1F–1G), consistent with theture. The finding that these molecules are coordinately regulated
lack of expression of Id1 in normal vasculature (see below). Theby Id1 suggests that inhibiting them in combination may be
reduction of Id copy number did not impede the very earlymore effective than inhibiting them separately. In summary, our
stages of tumorigenesis, since histological analysis detectedstudies provide a detailed analysis of antiangiogenic stress in
dysplastic changes in uterine glands in Id mutant animals.spontaneous murine tumors, identify proangiogenic factors reg-
Rather, it appears that the reduction of Id impairs the growthulated by Id1, and point to new strategies for the development
and/or survival of malignant uterine tissue, causing massiveand use of antiangiogenic therapy.
accumulation of necrotic tissue and blood.
The histological appearance of pheochromocytomas andResults
PINs was similar in Pten/ and Pten/ Id mutant animals (Sup-
plemental Figures S1H–S1M). The absence of an effect on theReduction of Id gene dosage does not affect incidence
histological appearance of these tumors in animals with reducedof tumorigenesis in the Pten/ tumor model
Id dosage is consistent with the observation that Id1 is notAfter a short latency, 100% of female Pten/ mice develop a
severe lymphocytic hyperplasia (DiCristofano et al., 1999). Loss overexpressed in the vasculature of these tumors (see below.)
278 CANCER CELL : OCTOBER 2003
A R T I C L E
Figure 1. Id deficiency impairs tumor cell survival
but does not affect tumor incidence or time of
onset in Pten/ model
A: Loss of two copies of the Id genes does not
delay the onset of lymphocytic hyperplasia in
Pten/ mice, while the loss of three copies con-
fers a slight but statistically significant delay. Bars
show mean age of onset  SD, and number of
mice in each category is given in parentheses.
B: Loss of Id genes does not decrease incidence
of uterine carcinoma in Pten/ mice. Number
of mice in each category is given in parentheses.
C and D: Loss of Id causes microscopic hemor-
rhage and tissue damage in Pten/ lymph hy-
perplasia. H&E staining reveals (C) intact tissue
in Pten/ (n  10) and (D) microscopic hemor-
rhage in Pten/Id1/ lymph hyperplasia (n 
10).
E: Gross examination reveals occasional hemor-
rhage and absence of visible necrosis in Pten/
uterine carcinomas (n  9), while frequent gross
hemorrhage and necrosis are observed in
Pten/ Id1/ (n  17) and Pten/ Id1/Id3/
(n  12) uterine tumors.
F and G: Loss of Id drastically affects tumor cell
survival in Pten/ uterine carcinoma. Histologi-
cal analysis detected (F) viable tissue in Pten/
Id-wild-type animals (n  9), while most sections
from Pten/ Id1/ animals contained (G) hem-
orrhage and necrosis (n 10). No tissue damage
was detected in Pten/ Id1/ nonneoplastic
uterine wall.
H: Quantitation of uterine tumor composition
demonstrates statistically significant reduction
of viable tumor tissue and increase in hemor-
rhage and necrosis in Pten/ Id1/ (n 10) and
Pten/ Id1/Id3/ (n  10) uterine tumors
as compared to Pten/ uterine malignancies
(n  9).
Scale bar, 25 m (C and D); 100 m (E and F).
Expression of Id1 and Id3 is confined to tumor and pheochromocytomas (Supplemental Figures S2A and S2B).
Thus, the increase in hemorrhage and necrosis observed in theendothelial cells
Changes in the appearance of the lymph and uterine malignan- lymph hyperplasias and uterine tumors is likely due to defects
in the vasculature within these tumors.cies in Id-deficient mice led us to investigate whether these
effects were due to the reduction of Id gene expression in tumor Upregulation of Id gene expression may also play a role in
human tumor angiogenesis. Previous studies detected Id1 andcells or endothelial cells. In situ and immunohistochemistry ex-
periments, including staining of adjacent sections with endothe- Id3 mRNA expression in endothelial cells of high-grade human
glial tumors (Lyden et al., 1999; Vandeputte et al., 2002). Immu-lial marker CD31, demonstrated that expression of both Id1
mRNA and Id1 protein were confined exclusively to the vascula- nohistochemistry has confirmed Id1 upregulation in endothelial
cells of a variety of other human malignancies, including endo-ture of hyperplastic lymph nodes of Pten/ animals (Figures
2A–2C). Id3 mRNA expression was also localized in blood ves- metrial and lymphoid tumors (Figures 2K and 2L), as well as lung,
stomach, large bowel, kidney, and ovarian adenocarcinomassels, although very low background levels of expression were
also detected in lymphocytic cells (Figure 2D). Analysis of (Supplemental Figures S2C–S2I).
Pten/ uterine carcinomas revealed that expression of Id1 pro-
tein and Id3 mRNA were also confined to endothelial cells (Fig- Tumor vasculature in the Id mutant background is
morphologically abnormal and functionally impairedures 2E–2H). In contrast, expression of Id1 protein and Id3
mRNA was virtually undetectable in endothelial cells of the unaf- CD31 immunohistochemistry of Pten/ hyperplastic lymphoid
tissue revealed numerous fine capillaries (Figure 3A). In contrast,fected uterine wall (Figures 2G–2J). Interestingly, expression of
Id1 was weak or undetectable in malignancies devoid of necro- staining of Pten/ Id mutant lymph hyperplasia with CD31 re-
vealed anastomosing networks of enlarged, dilated, and irregu-sis or hemorrhage in the Id-deficient background, such as PINs
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larly shaped blood vessels (Figure 3B). There was a significant
increase in vascular density in tumors grown in the Id mutant
background as compared to wild-type (Figure 3C). The vascular
phenotype found in tumor tissue was very similar to that de-
scribed in the brain of Id/Id3/ embryos. However, it differed
from the stunted vasculature found in xenografts of Id-deficient
mice. The extent of vascular malformation appeared to be simi-
lar in tissues lacking two or three copies of the Id genes in
different combinations (Supplemental Figures S3A–S3C).
Uterine carcinomas in Pten/ animals are well-vascularized
malignancies (Figure 3D). The extreme damage to uterine carci-
noma tissue observed in the Id-deficient background hampered
detailed analysis of vascular markers. However, in a few cases
of uterine carcinoma in Pten/ Id1/ Id3/ mice with viable
tumor tissue still detectable, vascular malformations very similar
to those found in lymph hyperplasia and Id1/Id3/ embryos
could be seen (Figure 3E). Areas of extensive necrosis sur-
rounded malformed vasculature (Figure 3F). The normally Id-
negative vasculature in the intact uterine wall appeared normal
(Figure 3G).
Immunodetection of hypoxia-inducible factor 1 (HIF-1),
a primary regulator of hypoxia-inducible genes (Harris, 2002),
provided evidence that morphologically abnormal Id mutant
vasculature is also functionally impaired. Normally, mammalian
cells are localized within 100–200 m of blood vessels because
they require oxygen and nutrients for their survival (Harris, 2002;
Carmeliet and Jain, 2000). In agreement with this observation,
hypoxic cells in Pten/ animals with intact Id alleles were local-
ized several cells away from blood vessels as revealed by stain-
ing adjacent sections with CD31 (Figures 3H and 3I). In contrast,
large numbers of hypoxic cells were present in the immediate
vicinity of Id mutant blood vessels despite the increased vascu-
lar density (Figures 3J and 3K).
In order to further characterize Id mutant vasculature, we
used high molecular weight fluorescent dextran to compare the
vascular permeability of tumor vasculature in the Id-wild-type
and mutant background. Reduction of Id gene expression
causes increased vascular permeability in the lymphocytic hy-
perplasias (Figures 3L and 3M).
Contribution of BM-derived CEPs to neovasculature
of Pten/ tumors
Previous work has shown that vascularization of xenografts
relies predominantly on CEPs, mobilization of which is impaired
in the Id-deficient background. Bone marrow transplantation
from a wild-type donor restores angiogenesis in xenografts of Id
mutant mice. Incorporation of BM-derived, vascular endothelial
growth factor receptor 2-positive (VEGFR2) CEPs was seen
in close to 100% of xenograft neovessels, which were also
surrounded by donor-derived VEGFR-1 myeloid cells. Mobili-
zation and incorporation of BM CEPs was not a result of bone
C and D: Id1 (n  6) and Id3 (n  4) expression, respectively, in Pten/
lymphocytic hyperplasia. Arrows point to blood vessels.
Figure 2. Expression of Id genes is confined to tumor vasculature G and H: Id3 expression in blood vessels of Pten/ uterine carcinoma and
uterine wall (n  6), dark and light field, respectively. Arrows point to Id3-A, E, and I: Id1 staining of Pten/ (A) lymph hyperplasia (n  8), (E) uterine
carcinoma (n  6), and (I) nonneoplastic uterine wall (n  6). negative blood vessels of uterine wall.
K and L: Id1 expression in blood vessels of human lymphomas (6/7) andB, F, and J: CD31 staining of adjacent sections of Pten/ (B) lymph hyperpla-
sia (n  8), (F) uterine carcinoma (n  6), and (J) nonneoplastic uterine endometrial adenocarcinomas (3/3), respectively.
Scale bar, 25 m (A, B, E, F, and I–L); 50 m (C, D, and G–H).wall (n  6).
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Figure 3. Tumor vasculature in the Id mutant background is morphologically abnormal and functionally deficient
A, B, D, and E: CD31 staining highlights normal blood vessels in Pten/ (A) lymph hyperplasia (n  8) and (D) uterine carcinoma (n  6) and dilated mutant
blood vessels in Pten/Id1/ (B) lymph hyperplasia (n  8) and (E) uterine carcinoma (n  3). Arrows point to dilated anastomosing vessels in Id mutant
lymph hyperplasia.
C: Microvessel density in Pten/ Id1/ (n  5) and Pten/ Id1/Id3/ (n  5) lymph hyperplasias was significantly higher than microvessel density in
Pten/ (n  5) lymph hyperplasias.
F and G: Loss of the Id1 gene affects cell survival only where it is normally expressed in vasculature. In Pten/ Id1/ uterine carcinoma, (F) areas with
mutant vasculature are surrounded by areas of extensive necrosis, while (G) nonneoplastic uterine wall remains unaffected and has morphologically
normal vasculature. Arrows point to morphologically normal blood vessels in the uterine wall.
H–K: Oxygen delivery is impaired in lymph hyperplasia with mutant vasculature, causing tumor cells to become hypoxic. HIF1 (H and J) and CD31 (I and
K) staining of adjacent sections reveals that in (H and I) Pten/ Id-wild-type lymph hyperplasia, hypoxic cells are located at a considerable distance from
blood vessels (n  5), while in (J and K) Pten/ Id1/ lymph hyperplasia, increased numbers of hypoxic cells are clustered in close proximity to vessels
(n  5).
L and M: Loss of Id1 increases permeability of tumor vasculature. Injection of high MW fluorescent dextran demonstrates the increased permeability to this
molecule in Id1 mutant tissue, as evidenced by (L) the vessel-associated staining in Pten/ Id-wild-type lymph hyperplasia (n  4) when compared to (M)
diffuse staining in Pten/ Id1/ lymph tumors (n  4).
Scale bar, 25 m (A, B, D, E, and H–M); 100 m (F and G);
marrow transplantation per se, since bone marrow transplanta- Id1/Id3/ animals (Figures 4A and 4B). In contrast, LacZ
cells were detected in blood vessels of uterine carcinomas fromtion from an Id mutant donor fails to restore angiogenesis in Id
mutant mice (Lyden et al., 2001). both Pten/ and Pten/ Id1/Id3/ animals (Figures 4C and
4D). In order to confirm that BM-derived LacZ cells were givingGiven the significant differences between the behavior of
xenografts and Pten/ tumors in the Id mutant background, rise to endothelial cells, we performed staining with CD31 and
observed that some of the CD31 cells were also LacZ (Figurewe were interested in investigating the origin of vasculature in
spontaneously arising tumors. Lethally irradiated Pten/ and 4E). On average, 16% and 16.5% of CD31-positive vessels were
LacZ in Pten/ and Pten/ Id1/Id3/ animals, respectivelyPten/ Id1/Id3/ mice were reconstituted with bone marrow
from Rosa 26 mice expressing a -gal transgene in all of their (Figure 4G). Other LacZ cells were observed to be negative
for CD31 and localized in the immediate vicinity of blood vesselstissues. Lymph hyperplasias and uterine carcinomas developing
in these animals were analyzed for incorporation of LacZ cells (Figure 4F). Since BM-derived xenograft vasculature was asso-
ciated with LacZVEGFR1 myeloid cells (Lyden et al., 2001),into neovasculature and presence of VEGFR1 LacZ and VEG-
FR2LacZ cells. we performed staining with this marker and observed that LacZ
cells associated with vasculature in uterine tumors were alsoNo appreciable incorporation of LacZ cells was seen in
vasculature of lymph hyperplasias from either Pten/or Pten/ positive for VEGFR1 (Figures 4H and 4I). LacZ vessels were
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Figure 4. Contribution of BM-derived CEPs to
neovasculature of Pten/ tumors
A and B: No LacZ blood vessels were detected
in either (A) Pten/ (n  5) or (B) Pten/ Id1/
Id3/ (n 8) lymph hyperplasias post bone mar-
row transplant from Rosa 26 mice.
C and D: Under the same conditions, incorpora-
tion of LacZ cells was seen in both (C) Pten/
(n  5) and (D) Pten/ Id1/ Id3/ (n  8)
uterine carcinoma tumors.
E: Incorporation of LacZ cells into blood vessels
was verified by counterstaining LacZ cells with
CD31 (n  13). Arrows point to the LacZ cells
that also stain for CD31.
F: Numerous LacZbut CD31-negative cells were
also observed to closely associate with blood
vessels (n  13).
G: 16.5% and 16% of CD31-positive blood vessels
were observed to incorporate LacZ endothelial
cells in Pten/ (n  5) and Pten/ Id1/ Id3/
(n  8) uterine carcinomas, respectively.
H and I: Staining adjacent sections with (I)
VEGFR1 demonstrated that the majority of (H)
LacZ cells in close proximity of blood vessels are
VEGFR1 (n  13).
J and K: Staining of adjacent sections with (K)
VEGFR2 revealed that (J) LacZ cells in blood
vessels are VEGFR2.
L: Quantitation of uterine tumors’ composition
revealed that percentage of viable tumor, hem-
orrhage, and necrosis found in Pten/ (n  5)
and Pten/ Id1/Id3/ (n  8) post bone mar-
row transplantation were no longer significantly
different from each other.
Scale bar, 25 m (A–D and H–K) 10 m (E and F).
seen to express both VEGFR1 and VEGFR2 (Figures 4H–4K). Id1 regulates several proangiogenic surface proteins
The fact that Id genes control the expression of other genesIncorporation of LacZVEGFR2 cells into blood vessels pro-
vides evidence that BM-derived CEPs are capable of contribut- prompted us to use DNA microarrays to evaluate differences
in gene expression between Id-wild-type and mutant tissues.ing to spontaneous tumor neoangiogenesis. LacZVEGFR2
cells were also occasionally seen around vessels, possibly rep- Initial experiments utilized whole tumor tissue since Id1 is ex-
pressed exclusively in the tumor vasculature, and thus detectedresenting migrating CEPs (Figures 4J and 4K).
Since BM-derived CEPs and myeloid cells restored angio- changes in expression would, at least partially, reflect the
changes in endothelial cells. We chose to compare gene expres-genesis and tumor growth in xenografts of Id mutant mice (Ly-
den et al., 2001), we evaluated whether bone marrow transplant sion in hyperplastic lymphoid tissue from Pten/ Id1/ and
Pten/ Id1/mice, since the extensive hemorrhage and necro-reduced hemorrhage and necrosis in Pten/ Id1/Id3/ mice.
Quantitation of tumor composition in Pten/ Id1/Id3/ mice sis present in uterine carcinoma prevented rigorous analysis.
Hierarchical clustering analysis (Eisen et al., 1998) was usedreconstituted with LacZ wild-type bone marrow indicated that
the presence of BM-derived CEPs dramatically increased viable on the filtered data set to visualize genes showing consistent
expression profiles across individual experiments (Figure 5A).tumor tissue and reduced hemorrhage and necrosis as com-
pared to untransplanted Pten/ Id1/Id3/ mice (Figure 4L We mainly focused on genes that were previously known to be
involved in angiogenesis and whose expression was downregu-and 1H). Pten/ Id1/Id3/animals still exhibited more hem-
orrhage and necrosis and less viable tumor tissue than Pten/ lated in Id1 mutant samples. We reasoned that such genes
would be potential targets for antiangiogenic therapy. The fol-mice, but these measurements were no longer significantly dif-
ferent in Id-wild-type and mutant mice (Figure 4L and 1H). Our lowing genes met these criteria: 4 integrin, 6 integrin, fibro-
blast growth factor receptor-1 (FGFR1), and metalloprotease-2results demonstrate that BM-derived CEPs have a functional
role in angiogenesis of some but not all spontaneously arising (MMP-2). We confirmed the array data using semiquantitative
PCR (Figure 5B). We also detected further downregulation oftumors in Pten/ mice.
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Figure 5. Downstream targets of Id1 in tumor angiogenesis
A: Genes were clustered to show consistency in independent Pten/ Id1/ versus Pten/Id1/ experimental comparisons (columns 1–8). As an example,
the expanded view of a downregulated gene cluster in Pten/ Id/ mice is shown. Each column represents data from one comparison and each row
is a gene on the array. The last column (9) is a control (Pten/ lymph hyperplasia versus normal lymph tissue). Arrows indicate genes used for further
analysis. Red: upregulation in Pten//downregulation in Pten/Id1/ tissue, green: downregulation in Pten//upregulation in Pten/Id1/ tissue; black:
no change; gray: missing values.
B: Confirmation of microarray results. Semiquantitative RT-PCR was carried out on mRNA samples obtained from Pten/Id-wild-type mice (lanes 1–3),
Pten/ Id1/ Id3/ mice (lanes 4–6), and Pten/Id1/Id3/ mice (lanes 7–8).
C–J: Staining with (C and D) 4 integrin, (E and F) 6 integrin, (G and H) MMP-2, and (I and J) FGFR-1 in (C, E, G, and I) Pten/ Id-wild-type (n  5) and
(D, F, H, and I) Pten/ Id1/ (n  5) lymphocytic hyperplasia.
K: Results of experimental hybridizations did not detect upregulation of TSP-1 in Pten/ Id1/ hyperplastic lymph tissue, even though upregulation was
observed in Id1/ Id3 / MEFs when compared to wild-type MEFs.
L and M: Staining with TSP 1 did not reveal difference in expression between (L) Pten/ Id-wild-type (n 4) and (M) Pten/ Id1/ (n 4) lymph hyperplasia.
Scale bar, 10 m (C–J, L, and M).
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MMP-2 and FGFR-1 levels in the Id1/Id3/ background rela- Functional validation of the downstream targets
We used in vivo matrigel assays to establish whether loss oftive to Id1/Id3/ (Figure 5B), suggesting that Id3 may regulate
function, either separately or in combination, of 64 integrins,these factors as well.
FGFR-1, and MMP-2 is sufficient to account for the angiogenicImmunohistochemistry revealed that 4 integrin localized
defects in Id mutant mice. Analysis of VEGF-impregnated matri-exclusively to endothelial cells (Figure 5C). In agreement with
gel plugs from wild-type animals revealed multiple channelsthe microarray results, Pten/ tissue expressed higher levels
created by endothelial cells (Figure 7A). Matrigel-plug-implantedof this molecule than Pten/ Id1/ tissue, where expression
Id1/Id3/ animals fail to form endothelial tubes (Lyden et al.,was very weak (Figure 5D, Supplemental Figure S3D). Immuno-
2001), and the numbers of invading endothelial cells are lowhistochemistry also showed that the 6 integrin subunit local-
and mostly confined to the periphery of the plugs (Figure 7B).ized exclusively to endothelial cells (Figure 5E). However, no
When a blocking antibody to 6 integrin (Zent et al., 2001)obvious difference in staining intensity of 6 integrin was de-
was added to matrigel injected into wild-type mice, a partialtected in the Id1 mutant background (Figure 5F). The change
phenocopy of Id mutant angiogenic defect was seen. Endothe-in expression, confirmed by RT-PCR, is most likely below the
lial cells failed to form luminized channels, but the numbers ofsensitivity of immunohistochemical detection.
invading endothelial cells were greater than those seen in the
Microarray analysis also showed consistent downregulation
matrigel plugs of Id mutant mice. An isotype-matched control
of FGFR-1 and MMP-2 in Pten/ Id1/ tissue (Figures 5A and antibody did not inhibit formation of luminized vessels (Figures
5B). Both FGFR-1 and MMP-2 are important regulators of tumor 7C and 7D).
angiogenesis (Powers et al., 2000; Haas and Madri, 1999), and The antiangiogenic phenotype associated with inhibition of
both are expressed in endothelial cells in Pten/ tissue (Figures the 6 integrin subunit may be due to the blockade of 61
5G and 5I). We also detected diminished expression of these integrin rather than 64. However, our microarray results sug-
molecules by immunohistochemistry in the Pten/Id1/ blood gest that the defect involves downregulation of 64 rather than
vessels (Figures 5H and 5J, Supplemental Figure S3D). 61 integrin since 6 and 4 integrins exhibited consistent
To further confirm that downregulation of identified angio- downregulation in Id1/ tissue in multiple independent experi-
genic factors in Id1/ tissue is specific to endothelial cells, we ments, whereas the levels of 1 fluctuated.
isolated endothelial cells from Id1/ and Id1/ lymph hyperpla- We also tested a blocking antibody to FGF receptors (Mei-
sias by modifying a previously published protocol (St Croix et tinger et al., 2001), which primarily interferes with FGFR-1, in the
al., 2000) (Figure 6A). The purity of isolated endothelial cells matrigel assay. Neutralizing FGFR1 inhibited endothelial tube
was 90%–95% as assessed by immunofluorescence with CD31 formation and resulted in decreased numbers of invading endo-
thelial cells, producing a phenotype very similar to that ofand von Willebrand factor (Figures 6B–6E). RT-PCR analysis
Id1/Id3/ mice. Addition of control antibody to matrigel didrevealed that Id1/ endothelial cells expressed diminished lev-
not inhibit tube formation (Figures 7E and 7F).els of 6 and 4 integrins, MMP-2, and FGFR1 (Figure 6F),
Peptide gelatinase inhibitor, which preferentially targetsvalidating results of the initial analysis performed on whole tumor
MMP-2 (Koivunen et al., 1999), was used to block MMP-2 func-tissue.
tion in the matrigel assay. The resulting phenotype was moreT7-based linear amplification of RNA obtained from Id1-
severe than that seen with 6 and FGFR-1 blocking antibodies.wild-type and -mutant endothelial cells allowed us to carry out
Virtually no endothelial cells were seen to invade the matrigeladditional microarray experiments, which again confirmed down-
plugs, with the majority localized at the edge of the implant.regulation of FGFR1, MMP-2, 6, and 4 integrins in Id1/
Matrigel plugs impregnated with vehicle alone formed endothe-endothelium (Table 1). We also found that a number of other
lial tubes (Figures 7G and 7H). Decreased levels of MMP-2 mayangiogenesis-related genes were downregulated 2- to 6-fold in
therefore account for the decreased numbers of the invadingthe Id1/ background, such as members of ephrin, the insulin-
endothelial cells seen in matrigel plugs of Id mutant animals.like growth factor 2 (IGF2), and transforming growth factor 
Thus, we demonstrate that combined downregulation of(TGF) families, as well as genes encoding extracellular matrix
MMP-2 and FGFR-1 may account for the reduced endothelial
(ECM) proteins and cell adhesion factors (Table 1). In addition,
cell invasion and tube formation seen in Id-deficient mice. We
6-fold upregulation of Hif1 was detected in Id1/ endothelial demonstrate that 6 integrin also plays a role in endothelial
cells (Table 1). tube formation, with its effect likely to be due to a reduction in
A recent study reported upregulation of TSP-1 in Id1/ a 64 integrin levels.
MEFs, and elevated levels of TSP-1 have been proposed to
account for the angiogenic defect in Id1 mutant mice (Volpert Discussion
et al., 2002). Our experiments with Id-wild-type and Id1/Id3/
MEFs confirmed the findings by Volpert et al. in that experimen- In this study, we investigate the consequences of reduced ex-
tal system (Figure 5K). However, we were unable to find consis- pression of Id1 and Id3 genes on the development and progres-
tent upregulation of TSP-1 in Id1/ spontaneously arising tu- sion of spontaneously arising malignancies in the Pten/ mu-
mors (Figure 5K). No upregulation of TSP-1 was seen in the rine tumor model. We report that deficiency of Id genes in tumor
purified Id1/ endothelial cells by either RT-PCR or array analy- endothelial cells, where they are usually expressed, causes for-
sis (Figure 6F, data not shown). Immunohistochemistry also mation of anastomosing and dilated blood vessels that exhibit
failed to detect upregulation of TSP-1 in tumor cells, tumor increased vascular permeability. The function of malformed tu-
stroma, or tumor endothelial cells grown in Id1/ background mor vasculature in Id mutant mice was impaired, since tumor
(Figures 5L and 5M). Thus, upregulation of TSP-1 cannot explain cells located in close proximity to these vessels experience
hypoxia. Chronic hypoxia impairs cell survival (Harris, 2002),the angiogenic defect seen in Pten/Id1/ tumors.
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Figure 6. Endothelial cell isolation and analysis
A: Scheme for isolation of pure EC populations
from tumors of Id1-wild-type and mutant mice.
B–E: Immunofluorescence was used to assess pu-
rity of EC preparations. Isolated cells were
counted using (B) DAPI stain, and their identity
confirmed via (C) CD31 staining of cell mem-
brane (the beads used to isolate cells are also
positive) and (D) Von Willebrand factor staining
of intracellular Weibel-Palade bodies. (E) Merg-
ing of images demonstrates that cells express
both CD31 and vWF.
F: Semiquantitative RT-PCR confirmed that ex-
pression of candidate genes identified in general
screen was specifically downregulated in endo-
thelial cells, while expression of TSP-1 was un-
changed.
G: Scatter plot showing normalized Log2 ratios
profiles. Comparison of array data from RNA am-
plified from two independent Id1/ tumor endo-
thelium samples (left) and from RNA amplified
from Id1/and Id1/ tumor endothelium (right).
and, accordingly, we found varying degrees of necrosis and under severe angiogenic stress, the behavior of xenografts is
often different from that of spontaneously arising tumors. Thehemorrhage in Pten/ Id mutant tumors lacking functional tu-
mor vasculature. While in the case of lymphocytic hyperplasia, growth of Pten/ Id mutant lesions differed significantly from
the behavior of B6RV2 lymphoma and B-CA breast cancer xeno-impaired vasculature resulted in pinpoint hemorrhages, uterine
carcinoma cells proved to be more susceptible to hypoxia, and grafts, which completely failed to grow when tested in Id1/
Id3/ animals (Lyden et al., 1999). Importantly, the vascularvery little viable tissue was found in uterine masses grown in
Id mutant animals. These findings indicate that certain tumors phenotype itself differed significantly between xenografts and
spontaneously arising tumors in Id mutant animals: the angio-could be more susceptible than others to the effects of antiangi-
ogenic therapy as a single therapeutic modality. Loss of Id may genic defect manifested as occluded and stunted vessels in LLC
xenografts of Id mutant animals (Lyden et al., 1999), whereas inmake tumors more susceptible to conventional treatment, since
increased vascular permeability would result in increased deliv- Pten/ tumors, reduced Id gene expression produced anas-
tamosing and dilated vasculature very similar to that found inery of therapeutic drugs to tumor cells that are already hypoxic,
and thus, more susceptible to a “second hit” such as chemother- the developing neuroepithelium of Id1/Id3/ embryos (Lyden
et al., 1999). Thus, our results suggest that xenograft studiesapy. Indeed, it has been shown recently that loss of Id genes
synergizes with 17-AAG drug treatment to completely suppress provide only limited insight into behavior of spontaneously aris-
ing tumors, and genetic tumor models may be more appropriatethe growth of her2/neu driven mammary carcinomas in mice
(de Candia et al., in press). for testing antiangiogenic agents.
Theories of tumor angiogenesis postulate, based largely onWe prove that Id1 and Id3 genes play a crucial role in tumor
angiogenesis, since loss of these genes causes vascular defects the results of xenograft experiments, that tumors are unable to
grow past a few millimeters without a functional neovasculaturein both xenografts and the more physiologically relevant genetic
tumor models. However, our results also highlight the fact that, (Kerbel, 2000). Our results provide evidence that, in physiologi-
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Table 1. Genes differentially expressed in Id1/ versus Id1/ endothelial cells in lymphoid hyperplasias
Genes downregulated in Id1/ EC
Confirmed targets 6 integrin (AW556992)
4 integrin (AA407046)
Fibroblast growth factor receptor 1 (AW557998)
MMP2 (M84324)
TGF/BMP family BMP4 (AW537809)
TGF- induced transcript 4 (AW546174)
IGF family IGF 2 (AW538165)
IGF2 receptor (AW556473)
IGF binding protein 3 (AW557928)
Ephrins Ephrin A1 (AA409240)
Ephrin receptor A2 (AW545284)
Ephrin receptor B4 (Z49085)
Cell-cell adhesion Protocadherin 13 (AW557174)
Cadherin 11 (AW555163)
Junction plakoglobin (AW539609)
Junction cell adhesion molecule (AW557063)
ECM proteins Procollagen, type V, 2 (AW558340)
Procollagen, type XVIII, 1 (AU042961)
Laminin 5 (AA408762)
Laminin 1 (AW546446)
Fibronectin 1 (AW547266)
Genes upregulated in Id1/ EC
Transcriptional regulation/hypoxia Hypoxia-inducible factor 1, alpha subunit (AW543477)
ECM Syndecan-binding protein (AW537357)
Chondroitin-sulfate proteoglycan (AW546323)
TGF/BMP family TGF-induced (betaig-h3) (AW546788)
cal models of tumorigenesis, tumor growth is not entirely pre- to combined downregulation of MMP-2 and FGFR-1 and 64
integrin. 64 integrin is expressed in endothelial cells in vivo,vented under these conditions. The difference in susceptibility
to Id loss between xenografts and spontaneously arising tumors but its function has not been established (Kennel et al., 1992).
Multiple lines of evidence indicate that MMP-2 is an importantmay lie in the different origins of tumor endothelial cells. In
spontaneous tumor angiogenesis, vessels can potentially sprout regulator of angiogenesis (Haas and Madri, 1999), and downreg-
ulation of this molecule in xenografts was previously seen in Id-from co-opted neighboring vasculature or be recruited as BM-
derived CEPs (Holash et al., 1999; Rafii, 2000). Previous work deficient backgrounds (Lyden et al., 1999). FGFR-1 is expressed
in endothelial cells as a primary receptor for bFGF, a potenthas shown that vascularization of xenografts, however, relies
mainly on CEPs, mobilization of which is blocked in the Id- angiogenic growth factor (Nakamura et al., 2001). Previous find-
ings suggest that these angiogenic molecules may lie in thedeficient background. Thus, the less dramatic effect on Pten/
lymph hyperplasia in the Id mutant background may be due to same pathway: bFGF upregulates the expression of 64 integ-
rins and MMP-2 activity in endothelial cells in vitro (Klein et al.,co-option of local vasculature in these lesions. Interestingly,
even among xenografts, LLC growth, which has a lower contri- 1993; Pfeifer et al., 2000), and MMP-2 induces the migration
of epithelial cells by cleaving and regulating the function ofbution of BM-derived precursors, is less affected in Id mutant
backgrounds than B6RV2, which derives its endothelium almost laminin-5, a recognized ligand for 64 integrin (Giannelli et al.,
1997). Thus, if the same pathway operated in endothelial cells,exclusively from CEPs. In spontaneous tumors, contribution of
BM-derived cells to tumor neovessels also differs depending loss of Id may short-circuit it by downregulation of three of its
critical components.on the tumor type. BM-derived CEPs contributed to 16% of
neovessels in Pten/ uterine carcinomas, while CEP contribu- Recently, transcription factor Egr-1 has been implicated in
the activation of bFGF, and loss of Egr-1 produces an antiangio-tion to vasculature of lymph hyperplasia was undetectable. Im-
portantly, the effect of Id loss was much more profound on genic phenotype similar to that of Id mutant animals (Fahmy et
al., 2003; Lyden et al., 1999, 2001). Interestingly, Egr-1 has alsothe viability of uterine carcinomas than the lymph hyperplasias,
which may be due to the dependence on CEPs in the former been shown to directly activate Id1 expression (Tournay and
Benezra, 1996). It is possible that the antiangiogenic defect incase and cooption and sprouting of local vessels, less affected
by Id loss, in the latter. The non-BM-derived vessels formed in Egr-1-deficient animals is partially due to subsequent downreg-
ulation of Id proteins and their targets, bFGF and its receptor.the lymph hyperplasia are at least partially dependent on the
function of Id genes, as vasculature of the Id-deficient lymph Microarray analysis carried out on purified endothelial cells
also revealed downregulation of other proangiogenic factors,hyperplasias is morphologically and functionally abnormal.
Whether such tumor-specific responses are observed to corre- such as members of the ephrin and IGF families, suggesting that
Id1 may be regulating several different angiogenic pathways.late with CEP utilization and inhibition by other antiangiogenic
agents needs to be evaluated. Ephrin A1 and its receptor EphA2, which are both expressed
in xenograft and spontaneous tumor vasculature (Ogawa et al.,Using microarray and matrigel assays, we also established
that the angiogenic defect in Id-deficient mice may be attributed 2000), have been shown to induce endothelial cell migration
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Upregulation of Hif1 mRNA in the Id mutant endothelium
suggests a possible direct transcriptional effect, since Hif1
promoter has four conserved E box consensus sequences,
which are recognized by bHLH transcription factors (Iyer et al.,
1998). Unlike upregulation of HIF1 protein in Id1/ tumor cells,
this increase is probably not a response to hypoxia, which is
mediated via posttranslational stabilization of the HIF1 subunit
(Harris, 2002).
While our results confirmed that TSP-1 is upregulated in Id
mutant MEFs, our analysis failed to detect similar upregulation
in Pten/ Id1/ tumors, suggesting that such a mechanism
cannot account for the angiogenesis defect observed in sponta-
neous tumors of these animals. The observed differences in
downstream targets of Id1 are most likely due to the differences
between the in vitro system used in the previous report (Volpert
et al., 2002) and the in vivo system used in this study, highlighting
the importance of using physiologically relevant models.
In this study, we demonstrate that, in the presence of severe
antiangiogenic stress, spontaneous tumors in mice can grow
beyond a limited size, although this growth is accompanied by
extensive hemorrhage and necrosis. Importantly, the extent of
tissue damage and the origin of the tumor vasculature is depen-
dent on the tumor type. It is our belief that the mouse models
of spontaneous tumors will provide the most useful test of the
effectiveness of antiangiogenic therapies alone or in combina-
tion with standard chemotherapeutics. Such analysis will be
instrumental in realizing the promise of antiangiogenic therapies
for the treatment of human cancers.
Experimental procedures
Figure 7. Angiogenic defects associated with blocking downstream targets
of Id1 in vivo Generation of Id-mutant Pten mice
Pten/ and Id1/ Id3/ mice, both in a mixed C57B6/129Sv background,A and B: H&E staining of matrigel plugs reveals multiple invading cells ar-
were crossed to generate Pten/ Id1/ Id3/ mice that then were crossedranged in endothelial tubes in (A) wild-type animals (n  10) and no endo-
thelial channels and greatly reduced cell numbers in (B) Id1/Id3/animals with each other to generate Pten/ mice with intact Id copies or Pten/
(n  6). mice lacking Id copies in different combinations. All mice were genotyped
C–H: Inhibition of candidate genes in matrigel assay in vivo. Wild-type mice by PCR according to previously published protocols (Lyden et al., 1999;
were implanted with matrigel premixed with (C) matched isotype control DiCristofano et al., 1999) and maintained in compliance with IACUC guide-
antibody (n  3) or (D) 6 blocking antibody (n  10); (E) matched isotype lines.
control antibody (n  3) or (F) FGFR-1 blocking antibody (n  10); or (G)
vehicle alone (n  3) or (H) synthetic peptide with preferential activity
Histological analysis, immunohistochemistry, and in situ hybridization
against MMP2 (n  8).
Tumor tissue and Matrigel plugs were processed as previously describedScale bar, 25 m (A–H).
(Lyden et al., 1999, 2001). Primary antibodies used included antibodies to
CD31, 6 integrin (BD Pharmingen, CA), HIF1 (Novus Biologicals, CO),
TSP-1, MMP-2 (NeoMarkers, Inc., CA), CD31, Id1, FGFR1, 4 integrin (Santa
Cruz Biotechnology, CA), and VEGFR1 and 2 (Imclone Systems Inc., Newand in vitro capillary assembly as well as corneal and tumor
York, NY). For in situ hybridization, sections were hybridized to [-33P]UTPneovascularization (Brantley et al., 2002). EphB4 and its ligand
labeled antisense RNA probes as described (Jen et al., 1996).Ephrin B2 are critical in embryonic angiogenesis (Gerety et al.,
1999). EphB4 is preferentially expressed on veins, and its activa- Quantitation of tumor composition and vascular density
tion mediates endothelial cell migration and proliferation in vitro Sections from peripheral and central regions of a tumor were imaged at low
(Gerety et al., 1999; Steinle et al., 2002). IGF2 and its receptor, magnification and areas of tumor tissue, hemorrhage, and necrosis were
downregulated in Id1/ endothelial cells, also possess angio- evaluated using MetaMorph 6.1 program (Universal Imaging Software).
25–35 sections were evaluated per each tumor sample. Blood vessel densitygenic properties. IGF 2 induces endothelial cell migration and
was quantified by counting the total number of CD31 vessels across thetube formation, and upregulates expression of MMP-2 (Lee et
whole sections of tumors (4–6 sections for each tumor sample).al., 2000). Thus, downregulation of these factors in the Id1/
endothelial cells may be contributing to the antiangiogenic phe-
Semiquantitative assessment of immunohistochemistry intensitynotype of Id mutant animals. Future experimental work will be
Intensity of staining was estimated using MetaMorph 6.1 (Universal Imagingnecessary to establish connections between different angio-
Software), with intensity scale set to 0% for white and 100% for black. 4–8
genic pathways regulated by Id proteins. Interestingly, members images were evaluated for each sample.
of TGF/BMP and IGF families have been shown to regulate Id
gene expression (Ruzinova and Benezra, 2003; Prisco et al., Bone marrow transplantation and LacZ detection
2001), and our results suggest reciprocal regulation of these Experimental procedures were carried out as previously described (Lyden
et al., 2001).factors by Id.
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Permeability assay Matrigel assay
Assays were carried out as previously described (Lyden et al., 2001). MatrigelVascular permeability assay was performed as previously described
plugs were also impregnated with: 6 blocking antibody, matched isotype(Grunstein et al., 1999).
antibodies (BD Pharmingen, CA), MMP-2 inhibiting peptide (Oncogene Re-
search Products, San Diego, CA), and FGFR-1 blocking antibody (ChemiconTumor samples and RNA extraction
International, Temecula, CA) at previously published concentrations (ZentAll of the tumor samples were frozen in liquid nitrogen and stored at 80	C.
et al., 2001; Meitinger et al., 2001; Koivunen et al., 1999).RNA isolation was carried out by using the Invitrogen FastTrack 2.0 mRNA
kit (Invitrogen/Life Technologies, CA) and Micro RNA kit (Stratagene, CA).
Statistical analysisT7-based amplification was carried out by using RiboAmp kit (Arcturus, CA).
Student’s t test was used to determine statistical significance between exper-RNA quality and quantity was assessed via electrophoresis, UV spectropho-
imental groups. P 
 0.05 was considered significant and is indicated withtometry, or bioanalyzer (Agilent technologies, CA).
an asterisk over the value in Figures 1 and 2. P values of 
0.01 and 0.001
are indicated by double and triple asterisks, respectively.
cDNA microarrays and data analysis
Conversion of mRNA to double-stranded cDNA was performed by using Supplemental data
the superscript cDNA synthesis (Gibco/Life Technologies, CA). Amino-allyl All Supplemental Figures can be found at http://www.cancercell.org/cgi/
modified dUTP was incorporated into the cDNA. Indirect labeling was ac- content/full/4/4/277/DC1.
complished by incubating amino-allyl modified Cy3 or Cy5 dyes (Amersham,
NJ). A set of 15,000 sequence-verified mouse cDNA clones representing Acknowledgments
both known genes and ESTs obtained from National Institute of Aging (http://
lgsun.grc.nia.nih.gov/cDNA/15k.html) were PCR amplified, purified, and ro- We thank the staff of the MSKCC Molecular Core Facility and the CSH
botically spotted on glass slides (Stolarov et al., 2001). Arrays were pro- microarray shared resource for their technical assistance. This research was
cessed and hybridized according to protocols available on our web site supported by NIH MSTP grant GM07739 (to M.B.R.) and grants from NIH
(http://nucleus.cshl.org/microarray). After hybridization, the arrays were and Angiogenex (to R.B.).
scanned using a GenePix 4000 laser scanner (Axon Instruments, CA) at 10
M resolution to measure fluorescence. Raw data files generated by the
scanner software GENEPIX3 were imported into S-Plus (a mathematical/
statistical package from Insightful Corp, WA) for analysis. For normalization, Received: June 2, 2003
features for which R2 values were above 0.4 and 50% feature pixels were Revised: August 27, 2003
1 standard deviation above background pixels in both channels were consid- Published: October 20, 2003
ered. The data points were then median normalized and plotted. Experiments
were performed in duplicate with color reversals (four hybridizations per References
sample pair). Each comparison was performed in three different animal pairs.
Hierarchical clusters were generated by the Cluster program and visualized Bergers, G., Javaherian, K., Lo, K.M., Folkman, J., and Hanahan, D. (1999).
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0. These were considered noise and were elimi-
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in press.et al., 1999), TSP-1 (Volpert et al., 2002), FGFR-1, and GAPDH (Faloon et
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Endothelial cell isolation
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